Pediatric Cardiology

, Volume 35, Issue 1, pp 108–120 | Cite as

Risk Factors in the Origin of Congenital Left-Ventricular Outflow-Tract Obstruction Defects of the Heart: A Population-Based Case–Control Study

  • Melinda Csáky-Szunyogh
  • Attila Vereczkey
  • Zsolt Kósa
  • Balázs Gerencsér
  • Andrew E. Czeizel
Original Article


The aim of our project was to study possible etiological factors in the origin of congenital heart defects (CHDs) because in the majority of patients the underlying causes are unclear. Cases with different CHD entities as homogeneously as possible were planned for evaluation in the population-based large data set of the Hungarian Case Control Surveillance of Congenital Abnormalities. Dead or surgically corrected 302 live-born cases with different types of left-ventricular outflow tract obstructive defects (LVOT, i.e., valvular aortic stenosis 76, hypoplastic left heart syndrome 76, coarctation of the aorta 113, and other congenital anomalies of aorta 32) were compared with 469 matched controls, 38,151 controls without any defects, and 20,750 malformed controls with other isolated defects. Medically recorded pregnancy complications and chronic diseases were evaluated based on prenatal maternity logbooks, whereas acute diseases, drug treatments, and folic acid/multivitamin supplementation were analyzed both on the basis of retrospective maternal information and medical records. The results of the study showed the role of maternal diabetes in the origin of LVOT in general, while panic disorder was associated with a higher risk of hypoplastic left heart syndrome and ampicillin treatment with a higher risk of coarctation of the aorta (COA). High doses of folic acid had a protective effect regarding the manifestation of LVOT, particularly COA. In conclusion, only a minor portion of causes was shown in our study; thus, further studies are needed to understand better the underlying causal factors in the origin of LVOT.


Left-ventricular outflow-tract obstructive defects of the heart Valvular aortic stenosis Hypoplastic left heart syndrome Coarctation of the aorta Panic disorder Maternal diabetes 



This project was supported by the Hungarian Egészségügyi Tudományos Tanács Pályázati Irodája (Grant Office of Scientific Committee of Health Ministry) and Versys Clinics, Human Reproduction Institute, Budapest, Hungary.


  1. 1.
    Ács N, Bánhidy F, Puho E, Czeizel AE (2005) Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A Clin Mol Teratol 73:989–995CrossRefPubMedGoogle Scholar
  2. 2.
    Ács N, Bánhidy F, Puho HE, Czeizel AE (2006) Maternal panic disorders and congenital abnormalities: a population-based case–control study. Birth Defects Res A Clin Mol Teratol 76:253–261CrossRefPubMedGoogle Scholar
  3. 3.
    Bánhidy F, Dakhlaoui A, Puho HE, Czeizel AE (2011) Is there a reduction of congenital abnormalities in the offspring of diabetic pregnant women after folic acid supplementation? Congenit Anom 51:80–86CrossRefGoogle Scholar
  4. 4.
    Beckman RH (1995) Coarctation of the aorta. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP (eds) Moss and Adam heart disease in infants, children, and adolescents, 5th edn. Williams and Wikins, Baltimore, MD, pp 1111–1128Google Scholar
  5. 5.
    Botto LD, Olney RS, Erickson JD (2004) Vitamin supplements and the risk for congenital anomalies other than neural-tube defects. Am J Med Genet 125:12–21CrossRefGoogle Scholar
  6. 6.
    Botto LD, Lin AE, Riekle-Colarusso T, Malik S, Correa A (2007) Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 79:714–727CrossRefPubMedGoogle Scholar
  7. 7.
    Calzolary E, Garani G, Cocchi G, Magnani C, Rivieri F, Neville A (2003) Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). Eur J Epidemiol 18:773–780CrossRefGoogle Scholar
  8. 8.
    Carmichael SL, Shaw GM, Yang W, Abrams B, Edward J (2002) Maternal life event stress and congenital anomalies. Epidemiology 11:30–35CrossRefGoogle Scholar
  9. 9.
    Clark EB (1996) Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol 20:465–472CrossRefPubMedGoogle Scholar
  10. 10.
    Czeizel AE (1990) A case–control analysis of the teratogenic effects of co-trimoxazole. Reprod Toxicol 4:305–313CrossRefPubMedGoogle Scholar
  11. 11.
    Czeizel AE (1996) Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 62:179–183CrossRefPubMedGoogle Scholar
  12. 12.
    Czeizel AE (1997) The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 55:299–305CrossRefPubMedGoogle Scholar
  13. 13.
    Czeizel AE (2009) The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experiences: a critical evaluation of clinical and epidemiological models of human teratology. Expert Opin Drug Safe 8:283–303CrossRefGoogle Scholar
  14. 14.
    Czeizel AE (2011) Periconceptional folic acid-containing multivitamin supplementation for prevention of neural-tube defects and cardiovascular malformations. Ann Nutr Metab 59:38–40CrossRefPubMedGoogle Scholar
  15. 15.
    Czeizel AE, Dudás I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Eng J Med 327:1832–1835CrossRefGoogle Scholar
  16. 16.
    Czeizel AE, Sankaranarayanan K (1984) The load of genetic and partially genetic disorders in man. Congenital anomalies: estimates of detriment in terms of years of life lost and years of impaired life. Mutat Res 128:73–103CrossRefPubMedGoogle Scholar
  17. 17.
    Czeizel AE, Vargha P (2004) Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 191:790–794CrossRefPubMedGoogle Scholar
  18. 18.
    Czeizel AE, Kamarás J, Balogh Ö, Szentpéteri J (1972) Incidence of congenital heart defects in Budapest. Acta Paediat Acad Sci Hung 13:191–202PubMedGoogle Scholar
  19. 19.
    Czeizel AE, Intődy ZS, Modell B (1993) What proportion of congenital abnormalities can be prevented? Br Med J 306:499–503CrossRefGoogle Scholar
  20. 20.
    Czeizel AE, Tóth M, Rockenbaer M (1996) Population-based case control study of folic acid supplementation during pregnancy. Teratology 53:345–351CrossRefPubMedGoogle Scholar
  21. 21.
    Czeizel AE, Rockenbauer M, Siffel CS, Varga E (2001) Description and mission evaluation of the Hungarian case–control surveillance of congenital abnormalities, 1980–1996. Teratology 63:176–185CrossRefPubMedGoogle Scholar
  22. 22.
    Czeizel AE, Rockenbauer M, Sorensen T, Olsen J (2001) A population-based case–control teratologic study of ampicillin treatment during pregnancy. Am J Obstet Gynecol 185:140–147CrossRefPubMedGoogle Scholar
  23. 23.
    Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001) The teratogenic risk of trimethoprim-sulfonamides: a population-based case–control study. Reprod Toxicicol 15:637–646CrossRefGoogle Scholar
  24. 24.
    Czeizel AE, Petik D, Vargha P (2003) Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Safe 12:409–416CrossRefGoogle Scholar
  25. 25.
    Czeizel AE, Dobó M, Vargha P (2004) Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol 70:853–861CrossRefPubMedGoogle Scholar
  26. 26.
    Czeizel AE, Puho E, Ács N, Bánhidy F (2006) Inverse association between severe nausea and vomiting in pregnancy and some congenital abnormalities. Am J Med Genet 140A:453–462CrossRefGoogle Scholar
  27. 27.
    Dolk H, Loane M, Garne R, European Surveillance of Congenital Anomalies (EUROCAT) Working Group (2011) Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 123:841–849CrossRefPubMedGoogle Scholar
  28. 28.
    Ferencz C, Rubin JD, NcCarter RJ, Clark EB (1990) Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology 41:319–326CrossRefPubMedGoogle Scholar
  29. 29.
    Ferencz C, Loffredo CA, Rubin JD, Magee CA (1993) Epidemiology of congenital heart diseases. The Baltimore–Washington infant study: 1981–1989. Future Publication Co, Mount Kisco, NYGoogle Scholar
  30. 30.
    Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD (1997) Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore–Washington infant study: 1981–1989. Futura Publication Co, Armonk, NYGoogle Scholar
  31. 31.
    Fulton DR (2008) Congenital heart diseases in children and adolescent. In: Fuster V, Wals A, O’Rourke RA, Poole-Wilson P (eds) Hurst’s the heart, 12th edn. McGraw Hill Medical, New York, NY, pp 1855–1921Google Scholar
  32. 32.
    Gelb BD (2004) Genetic basis of congenital heart disease. Curr Opin Cardiol 19:110–115CrossRefPubMedGoogle Scholar
  33. 33.
    Goh YI, Bollano E, Einarson TR, Koren G (2006) Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 28:686–690Google Scholar
  34. 34.
    Heinonen OP, Slone D, Shapiro A (1977) Birth defects and drugs in pregnancy. PSG Publishing, Littleton, MAGoogle Scholar
  35. 35.
    Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and risk of birth defects. N Engl J Med 343:1608–1614CrossRefPubMedGoogle Scholar
  36. 36.
    Hoffman JIE, Kaplan S, Liberthson RR (2004) Prevalence of congenital heart disease. Am Heart J 147:425–439CrossRefPubMedGoogle Scholar
  37. 37.
    Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L (2009) Prevalence of severe congenital heart disease after folic acid fortification of grain products. Time trend analysis in Quebec, Canada. Brit Med J 338:b1673PubMedCentralCrossRefPubMedGoogle Scholar
  38. 38.
    Jenkins KJ, Correa A, Feinstein JA, Feinstein JA, Botto L, Britt AE et al (2007) Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on cardiovascular disease in the young. Endorsed by the American Academy of Pediatrics. Circulation 115:2995–3014CrossRefPubMedGoogle Scholar
  39. 39.
    Lammer EJ (2007) Maternal stressful life events and risk of birth defects. Epidemiology 18:356–361PubMedCentralCrossRefPubMedGoogle Scholar
  40. 40.
    Loffredo CA, Wilson PD, Ferencz C (2001) Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64:98–101CrossRefPubMedGoogle Scholar
  41. 41.
    McBride KL, Marengo L, Canfield M, Langlois P, Fixler D, Belmont JW (2005) Epidemiology of non-complex left ventricular outflow tract obstruction malformation (aortic valve stenosis, coarctation of the aorta, hypoplastic left heart syndrome) in Texas, 1999–2001. Birth Defects Res A Clin Mol Teratol 73:555–561PubMedCentralCrossRefPubMedGoogle Scholar
  42. 42.
    Mészáros M, Nagy A, Czeizel AE (1975) Incidence of congenital heart disease in Hungary. Hum Hered 25:513–519CrossRefPubMedGoogle Scholar
  43. 43.
    Molsted-Pederson L, Tygstrup I, Pederson J (1964) Congenital malformations in newborn infants of diabetic women. Lancet 1:1124–1126CrossRefGoogle Scholar
  44. 44.
    Pierpont ME, Basson CT, Benson DW, Gelb BD Jr, Giglia TM, Goldmuntz E et al (2007) Genetic basis for congenital heart defects: current knowledge. Circulation 115:3015–3038CrossRefPubMedGoogle Scholar
  45. 45.
    Pradat O, Francannet C, Harris JA, Robert E (2003) The epidemiology of cardiovascular defects. Part I. A study based on data from three large registries of congenital malformations. Pediatr Cardiol 24:195–221CrossRefPubMedGoogle Scholar
  46. 46.
    Puho E, Métneki J, Czeizel AE (2005) Maternal employment status and isolated orofacial clefts in Hungary. Centr Eur J Publ Health 13:144–148Google Scholar
  47. 47.
    Reller MD, Strickland MJ, Riehle-Colarusso F, Mahle WT, Correa A (2008) Prevalence of congenital heart defects in Metropolitan Atlanta, 1998–2005. J Pediatr 153:807–813PubMedCentralCrossRefPubMedGoogle Scholar
  48. 48.
    Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT, The EuroMAP Group (2001) Recall bias in a case–control study on the use of medicine during pregnancy. Epidemiology 12:401–466CrossRefGoogle Scholar
  49. 49.
    Shepard TH, Lemire RJ (2004) Catalog of teratogenic agents, 11th edn. Johns Hopkins University Press, Baltimore, MDGoogle Scholar
  50. 50.
    Siu SC, Silversides CK (2010) Bicuspid aortic valve. J Am Coll Cardiol 55:2789–2800CrossRefPubMedGoogle Scholar
  51. 51.
    Torfs CT, Curry CJ, Harris JA (1991) The descriptive epidemiology of hypoplastic left heart, coarctation of the aorta, and aortic stenosis. Teratology 43:448–449Google Scholar
  52. 52.
    van Beynum IM, Kapusta L, Bakker MK, den Heijer M, Blom HJ, de Walle HE (2010) Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case–control study in the northern Netherlands. Eur Heart J 31:464–471CrossRefPubMedGoogle Scholar
  53. 53.
    Vereczkey A, Kósa Z, Csáky-Szunyogh M, Urbán R, Czeizel AE (2012) Birth outcomes of cases with left-sided obstructive defects of the heart in the function of maternal socio-demographic factors—A population-based case–control study. J Matern Fetal Neonatal Med 25:2536–2541CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Melinda Csáky-Szunyogh
    • 1
  • Attila Vereczkey
    • 2
  • Zsolt Kósa
    • 2
  • Balázs Gerencsér
    • 3
  • Andrew E. Czeizel
    • 4
  1. 1.Hungarian Congenital Abnormality RegistryNational Institute for Health DevelopmentBudapestHungary
  2. 2.Versys Clinics, Human Reproduction InstituteBudapestHungary
  3. 3.Alfréd Rényi Institute of MathematicsHungarian Academy of ScienceBudapestHungary
  4. 4.Foundation for the Community Control of Hereditary DiseasesBudapestHungary

Personalised recommendations